Why the study?
Angiopoietin-like proteins have diverse functions including regulation of chronic inflammation and angiogenesis, but their roles in cancer progression and therapeutic potential require synthesis.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
May guide ANGPTL-targeted cancer therapies; leaves open clinical utility pending prospective trials.
Angiopoietins play important roles in angiogenesis and the maintenance of hematopoietic stem cells. Angiopoietin-like proteins (ANGPTLs) are identified as proteins structurally similar to angiopoietins, and the ANGPTL family now consists of eight members. ANGPTLs are secretary proteins, and some ANGPTLs are not only angiogenic factors but also proteins with multiple functions such as glucose metabolism, lipid metabolism, redox regulation and chronic inflammation. Chronic inflammation is one of the key factors in carcinogenesis and cancer growth, proliferation, invasion and metastasis. ANGPTL 2, 3, 4, 6 and 7 are pro-inflammatory factors and regulate cancer progression, while ANGPTL1 inhibits tumor angiogenesis and metastasis. In this review, we describe the roles of ANGPTLs in cancer progression and discuss the possibility of disturbing the progression of cancer by regulating ANGPTLs expression.
No takes yet. Share an insight, caveat, or question.
Motoyoshi Endo (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: